Accelerated Stability Studies of Widely Used Pharmaceutical Substances Under Simulated Tropical Conditions
(1986; 119 pages) Voir le document au format PDF
Table des matières
Afficher le document1. Introduction
Afficher le document2. Index of degradable substances
Afficher le document3. Index of substances resistant to degradation
Fermer ce répertoire4. Stability experiments on degradable substances
Afficher le documentAcetylsalicylic acid
Afficher le documentAminophylline
Afficher le documentAmitriptyline hydrochloride
Afficher le documentAmmonium chloride
Afficher le documentAmphotericin B
Afficher le documentAmpicillin sodium
Afficher le documentAmpicillin trihydrate
Afficher le documentAntimony sodium tartrate
Afficher le documentAscorbic acid
Afficher le documentBacitracin
Afficher le documentBacitracin zinc
Afficher le documentBenzathine benzylpenicillin
Afficher le documentBenzylpenicillin potassium
Afficher le documentBenzylpenicillin sodium
Afficher le documentBephenium hydroxynaphthoate
Afficher le documentCalcium gluconate
Afficher le documentCalcium para-aminosalicylate
Afficher le documentCarbenicillin sodium
Afficher le documentCefalexin
Afficher le documentChloral hydrate
Afficher le documentChloramphenicol sodium succinate
Afficher le documentChlorphenamine hydrogen maleate
Afficher le documentChlorpromazine hydrochloride
Afficher le documentChlortetracycline hydrochloride
Afficher le documentCloxacillin sodium (monohydrate)
Afficher le documentCoal tar (washed)
Afficher le documentCodeine phosphate
Afficher le documentColecalciferol
Afficher le documentCresol
Afficher le documentDapsone
Afficher le documentDexamethasone sodium phosphate
Afficher le documentDicloxacillin sodium (monohydrate)
Afficher le documentDiethylcarbamazine dihydrogen citrate
Afficher le documentDoxycycline hyclate
Afficher le documentEmetine hydrochloride
Afficher le documentEphedrine
Afficher le documentEphedrine sulfate
Afficher le documentEpinephrine
Afficher le documentEpinephrine hydrogen tartrate
Afficher le documentErgocalciferol
Afficher le documentErgometrine hydrogen maleate
Afficher le documentErgotamine maleate
Afficher le documentErgotamine tartrate
Afficher le documentEthosuximide
Afficher le documentEthylmorphine hydrochloride
Afficher le documentFerrous sulfate
Afficher le documentFluphenazine decanoate
Afficher le documentFluphenazine hydrochloride
Afficher le documentFormaldehyde solution
Afficher le documentGentamicin sulfate
Afficher le documentGuanethidine sulfate
Afficher le documentHexylresorcinol
Afficher le documentHydralazine hydrochloride
Afficher le documentHydrocortisone sodium succinate
Afficher le documentHydroxocobalamin
Afficher le documentHyoscyamine sulfate
Afficher le documentImipramine hydrochloride
Afficher le documentIpecacuanha powder
Afficher le documentIsoprenaline hydrochloride
Afficher le documentIsoprenaline sulfate
Afficher le documentLidocaine hydrochloride
Afficher le documentMelarsoprol
Afficher le documentMercuric oxide yellow
Afficher le documentMetrifonate
Afficher le documentNaloxone hydrochloride
Afficher le documentNeomycin sulfate
Afficher le documentNystatin
Afficher le documentOrciprenaline sulfate
Afficher le documentOxytetracycline hydrochloride
Afficher le documentParomomycin sulfate
Afficher le documentPenicillamine
Afficher le documentPethidine hydrochloride
Afficher le documentPhenobarbital sodium
Afficher le documentPhenoxymethylpenicillin
Afficher le documentPhenoxymethylpenicillin calcium
Afficher le documentPhenoxymethylpenicillin potassium
Afficher le documentPhentolamine mesilate
Afficher le documentPhenylbutazone
Afficher le documentPilocarpine hydrochloride
Afficher le documentPilocarpine nitrate
Afficher le documentProcainamide hydrochloride
Afficher le documentProcaine benzylpenicillin
Afficher le documentProcaine hydrochloride
Afficher le documentProcarbazine hydrochloride
Afficher le documentPromazine hydrochloride
Afficher le documentPromethazine hydrochloride
Afficher le documentPyridoxine hydrochloride
Afficher le documentQuinine bisulfate
Afficher le documentQuinine dihydrochloride
Afficher le documentRetinol (Vitamin A)
Afficher le documentSalbutamol sulfate
Afficher le documentSenna leaf
Afficher le documentSilver nitrate
Afficher le documentSodium calcium edetate
Afficher le documentSodium lactate
Afficher le documentSodium nitrite
Afficher le documentSodium para-aminosalicylate
Afficher le documentSodium stibogluconate
Afficher le documentSulfacetamide sodium
Afficher le documentSulfadiazine sodium
Afficher le documentSulfadimidine sodium
Afficher le documentSuxamethonium chloride
Afficher le documentTetracaine hydrochloride
Afficher le documentTetracycline hydrochloride
Afficher le documentThiamine hydrochloride
Afficher le documentThiamine mononitrate
Afficher le documentThiopental sodium
Afficher le documentTolbutamide
Afficher le documentUndecylenic acid
Afficher le documentWarfarin sodium
 

Quinine bisulfate

Accelerated Degradation Experiment

Conditions

Procedure A:

30 days exposure at 50 °C and 100% relative humidity.

Procedure B:

30 days exposure at 50 °C and 100% relative humidity followed by 5 days at 70 °C and 100% relative humidity.

Appearance of the substance

The substance, originally in the form of colourless crystals or a white, crystalline powder changes after procedure A into pale yellow, crystalline agglomerates, the colour turning to yellow-brown after procedure B.

Gain of moisture

After procedure A:

30%

After procedure B:

50%

Chromatographic test

Adsorbent: Silica gel 60 F-254

Solution applied to the plate: Substance dissolved in methanol.

Solvent system:

ethyl acetate .............. 40 volumes
acetone ..................... 38 volumes
n-butanol .................. 24 volumes
ammonia 10% .......... 8 volumes

Development condition: The solvent is allowed to migrate until the front reaches a line 15 cm from the starting line.

Detection: The plate is examined under ultraviolet light at a wavelength of maximum output at about 254 nm and then at 365 nm. After spraying with a solution of potassium iodobismuthate the plate is examined in daylight.

Results: The reference solution of quinine bisulfate shows numerous spots of different intensities. After procedures A and B the intensity of some spots increase and additional secondary spots appear.

Ultraviolet spectrophotometry

No modification is observed in the spectrum or in the absorbances at the three maxima of solutions in methanol of the samples subjected to procedures A and B.

Gas-liquid chromatography

After procedures A and B: no change is observed.

Conclusion

Quinine bisulfate is subject to decomposition under accelerated degradation conditions.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013